P12821 (ACE_HUMAN) Homo sapiens (Human)
Angiotensin-converting enzyme UniProtKBProtein AtlasInterProSTRINGInteractive Modelling
Available Structures
65 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 4-10 |
Heteromer P05067; | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×SO4; 4×PEG; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 35-42 |
Heteromer P05067; | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 1×PG4; 1×P6G; | |||
| Human angiotensin-converting enzyme in complex with angiotensin-II |
Heteromer P01019; | 100.0 | 1×NAG; 2×CL; 1×ZN; 1×PE4; 1×NAG; 5×ACT; | |||
| Human angiotensin-converting enzyme in complex with BPPb |
Heteromer P01021; | 100.0 | 1×NAG; 3×CL; 1×SO4; 3×PE4; 1×ACT; | |||
| Structure of full-length, monomeric, soluble somatic angiotensin I-converting enzyme showing the N-… | monomer | 99.92 | 1×NAG; 2×NAG; 4×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 4×NAG; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 10-16 | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×GLU; 1×VAL; 1×ZN; 1×CL; 1×CA; 4×PEG; | |||
| Local refinement structure of the N-domain of full-length, monomeric, soluble somatic angiotensin I… | monomer | 99.84 | 1×NAG; 1×NAG; 4×NAG; 1×ZN; 2×NAG; | |||
| Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide IPP | monomer | 98.85 | 2×NAG; 1×ZN; 1×CL; 1×MG; 2×PGE; 1×12P; 1×XPE; 4×PEG; 5×EDO; 4×NAG; 1×BMA; | |||
| Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibito… | monomer | 98.85 | 1×NAG; 1×NAG; 1×8J9; 1×NAG; 2×ACT; 1×1PE; 3×EDO; 2×PEG; 1×P33; 1×ZN; 1×CL; 1×MG; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 1-16 | monomer | 98.85 | 1×NAG; 1×NAG; 1×ASP; 1×SER; 1×ZN; 1×CL; 1×NAG; 3×PEG; 2×P6G; | |||
| Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with BPPb | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×XPE; 4×EDO; 2×PEG; 4×BO3; 1×PGE; 1×ZN; 2×CL; 1×MG; | |||
| Human angiotenisn converting enzyme N-domain in complex with K-26 | monomer | 99.84 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×PE4; 1×P6G; 1×PEG; 1×K26; 1×9X6; | |||
| Structure of human somatic angiontensin-I converting enzyme N domain with lisinopril | monomer | 100 | 1×NAG; 2×NAG; 1×ZN; 1×CL; 1×LPR; 2×GOL; | |||
| Structure of human somatic angiontensin-I converting enzyme N domain | monomer | 100 | 2×NAG; 3×NAG; 1×ZN; 1×CL; 2×ACT; 1×GOL; | |||
| Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibito… | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×8JV; 1×ZN; 1×CL; 1×MG; 2×ACT; 1×1PE; 1×PEG; 2×EDO; | |||
| Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Omapatrilat. | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×FT8; 1×CL; 1×XPE; 1×PG4; 7×EDO; | |||
| Crystal structure of the open conformation of Angiotensin-1 converting enzyme N-domain. | monomer | 98.68 | 1×NAG; 1×NAG; 3×BO3; 2×BCN; 1×PEG; 5×EDO; 2×PGE; 1×ZN; 1×CL; 1×MG; 1×CA; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta fluo… | monomer | 98.52 | 1×NAG; 1×NAG; 1×NAG; 1×GLY; 1×NIY; 1×ZN; 1×CL; 3×PEG; | |||
| Crystal structure A of the Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhi… | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×BJ2; 1×CL; 1×MG; 3×PEG; 7×EDO; 2×ACT; 1×PE3; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with Ac-SD | monomer | 98.85 | 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG; 2×PEG; 1×P6G; 1×SAC; 1×ASP; | |||
| Crystal structure B of the Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhi… | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×BJ2; 1×CL; 1×MG; 2×PEG; 2×EDO; 2×ACT; 1×PGE; 1×BCN; | |||
| Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with … | monomer | 97.52 | 1×NAG; 1×NAG; 1×NAG; 2×BO3; 1×ZN; 1×1IU; 1×CL; 4×EDO; 1×PEG; 1×PGE; | |||
| Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Sampatrilat-Asp. | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×D0W; 1×CL; 1×PEG; 1×PG4; 1×MG; 1×EDO; 2×ACT; | |||
| Human Angiotensin converting enzyme N-domain in complex with a phosphinic tripeptide FI | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 1×PG4; 1×3EF; | |||
| Angiotensin Converting Enzyme N domain glycsoylation mutant (Ndom389) in complex with RXP407 | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×RX4; 1×P6G; 1×CL; 1×PEG; | |||
| human Angiotenisn converting enzyme N-domain in complex with Phosphinic tripeptide | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 1×3ES; 1×ZN; 1×CL; 3×PEG; 1×PG4; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with a domain-specific… | monomer | 98.85 | 1×NAG; 1×NAG; 1×NAG; 3×PEG; 1×P6G; 1×1IU; 1×ZN; 1×CL; | |||
| Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Sampatrilat. | monomer | 98.84 | 1×NAG; 1×NAG; 1×ZN; 1×D0Z; 2×CL; 1×NAG; 2×MG; 3×EDO; 1×PEG; 1×PG4; | |||
| Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with fosinoprilat | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×KS8; 5×PEG; 3×PGE; 2×PG4; 4×ACT; 4×EDO; 1×ZN; 1×CL; 1×CA; 1×NA; | |||
| Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibito… | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 3×PEG; 1×P33; 1×ACT; 2×EDO; 1×P6G; 1×ZN; 1×CL; 1×MG; 1×8KC; | |||
| Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with … | monomer | 97.51 | 1×NAG; 1×NAG; 1×NAG; 3×BO3; 1×ZN; 1×CL; 1×BJ2; 1×PGE; 1×PEG; 1×PG4; 4×EDO; 2×BCN; 1×CA; | |||
| Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with Lys-Pro | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×LYS; 1×PRO; 1×ZN; 1×CL; 3×PEG; 2×P6G; | |||
| Crystal structure of 'Res_S2 mutant human Angiotensin-1 converting enzyme N-domain in complex with … | monomer | 97.52 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×FT8; 1×CL; 1×XPE; 1×PGE; 2×EDO; 1×PEG; 1×BCN; 2×BO3; | |||
| Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide VPP | monomer | 98.84 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 2×EDO; 1×PG4; 1×PGE; | |||
| Local refinement structure of a single N-domain of full-length, dimeric, soluble somatic angiotensi… | monomer | 99.84 | 1×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×NAG; | |||
| Local refinement structure of the two interacting N-domains of full-length, dimeric, soluble somati… | monomer | 99.84 | 1×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×NAG; | |||
| Crystal structure of the open conformation of S2_S'-mutant human Angiotensin-1 converting enzyme N-… | monomer | 97.34 | 1×NAG; 1×NAG; 1×BCN; 2×PG0; 1×ZN; 1×CL; 1×CA; | |||
| Crystal structure of Angiotensin-1 converting enzyme C-domain with inserted symmetry molecule C-ter… | monomer | 99.15 | 1×NAG; 1×NAG; 1×ACT; 3×EDO; 1×ZN; 2×CL; | |||
| Crystal structure of human Angiotensin-1 converting enzyme C-domain in complex with Omapatrilat. | monomer | 99.15 | 1×NAG; 1×NAG; 1×ZN; 2×CL; 3×FT8; 1×IMD; 3×BO3; 1×P6G; 6×EDO; | |||
| Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibito… | monomer | 99.15 | 1×NAG; 1×NAG; 3×EDO; 1×ACT; 1×ZN; 1×8KC; 2×CL; 5×BO3; 1×1PE; 1×IMD; | |||
| Crystal structure of human testis Angiotensin-1 converting enzyme in complex with Sampatrilat. | monomer | 99.15 | 1×NAG; 1×NAG; 1×ZN; 1×D0Z; 2×CL; 2×IMD; 1×BO3; 3×EDO; 3×PEG; 1×PGE; | |||
| Crystal structure of human testis angiotensin-I converting enzyme mutant D465T | monomer | 99.83 | 1×NAG; 1×SO4; 2×CL; 1×ZN; 1×MLA; 1×PE4; 1×NAG; 2×ACT; | |||
| Human Angiotensin converting enzyme in complex with a phosphinic tripeptide FI | monomer | 100 | 1×NAG; 1×ZN; 2×CL; 3×ACT; 1×PEG; 1×3EF; 1×NAG; | |||
| Crystal structure of human testis Angiotensin-1 converting enzyme in complex with Sampatrilat-Asp. | monomer | 99.15 | 1×NAG; 1×NAG; 1×ZN; 2×CL; 1×1PE; 1×D0W; 1×BO3; 2×IMD; 6×EDO; 1×PEG; | |||
| Crystal structure of human testis angiotensin-I converting enzyme mutant R522K in complex with capt… | monomer | 99.83 | 1×NAG; 1×ZN; 2×CL; 1×X8Z; 1×ACT; 1×GOL; | |||
| Tesis ACE co-crystal structure with ketone ACE inhibitor kAF | monomer | 99.15 | 1×NAG; 2×NAG; 1×ZN; 2×CL; 1×KAF; | |||
| Crystal structure of human testis angiotensin-I converting enzyme mutant R522K | monomer | 99.83 | 1×NAG; 1×ZN; 1×CL; 1×SO4; 1×ACT; 1×PE4; | |||
| Human testis angiotensin converting enzyme in complex with K-26 | monomer | 100.0 | 1×NAG; 1×ACT; 1×PE4; 1×K26; 2×CL; 1×ZN; 1×NAG; | |||
| Testis ACE co-crystal structure with ketone ACE inhibitor kAW | monomer | 99.14 | 1×NAG; 2×NAG; 1×ZN; 2×CL; 3×ACT; 1×KAW; 1×GOL; | |||
| Crystal structure of human testis angiotensin-I converting enzyme mutant R522Q | monomer | 99.83 | 1×NAG; 1×ZN; 1×CL; 1×SO4; 1×ACT; 1×PE4; | |||
| Crystal structure of human testis angiotensin-I converting enzyme mutant E403R | monomer | 99.83 | 1×NAG; 1×ZN; 2×CL; 1×SO4; 1×PE4; | |||
| Local refinement structure of the C-domain of full-length, monomeric, soluble somatic angiotensin I… | monomer | 100 | 1×NAG; 2×NAG; 1×CL; 2×NAG; | |||
| Human Angiotensin converting enzyme in complex with phosphinic tripeptide | monomer | 100.0 | 1×NAG; 1×ACT; 2×CL; 1×ZN; 1×NAG; 1×EPE; 2×3ES; | |||
| Human tACE g13 mutant | monomer | 99.31 | 1×NAG; 1×NAG; 2×ACT; 2×CL; 1×ZN; | |||
| Structure of testis ACE with RXPA380 | monomer | 100.0 | 1×ZN; 2×CL; 1×RX3; | |||
| Complex of the anti-hypertensive drug enalaprilat and the human testicular angiotensin I-converting… | monomer | 100.0 | 1×GLY; 1×ZN; 2×CL; 1×EAL; | |||
| Complex of the anti-hypertensive drug captopril an the human testicular angiotensin I-converting en… | monomer | 100.0 | 2×NAG; 1×ZN; 1×MCO; 2×CL; | |||
| Crystal Structure of Human Angiotensin Converting Enzyme (Native). | monomer | 100.0 | 6×NAG; 1×ACT; 1×ZN; 1×NXA; 2×CL; | |||
| Crystal Structure of Human Angiotensin Converting Enzyme in complex with lisinopril. | monomer | 100.0 | 1×GLY; 1×ZN; 1×LPR; 2×CL; | |||
| Structural characterization of angiotensin-I converting enzyme in complex with a selenium analogue … | monomer | 99.83 | 1×NAG; 1×ZN; 2×CL; 1×NAG; 1×SLC; | |||
| Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibito… | monomer | 99.14 | 1×NAG; 1×NAG; 5×BO3; 1×IMD; 1×8JV; 1×PEG; 1×1PE; 2×EDO; 1×ZN; 2×CL; | |||
| Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibito… | monomer | 99.14 | 1×NAG; 1×NAG; 3×BO3; 1×8J9; 1×PEG; 2×EDO; 1×ZN; 2×CL; | |||
| Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with fosinoprilat | monomer | 99.13 | 1×NAG; 1×KS8; 1×NAG; 2×BO3; 1×ACT; 1×IMD; 3×EDO; 1×ZN; 2×CL; | |||
| Testis ACE co-crystal structure with novel inhibitor lisW | monomer | 99.13 | 1×NAG; 1×ZN; 2×CL; 1×LSW; | |||
| Human tACE mutant g1234 | monomer | 99.65 | 2×NAG; 1×ACT; 1×ZN; 2×CL; 1×NXA; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7q3y.1.A | monomer | 0.86 | 1×NAG; 1×ZN; | 99.92 | ||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 7q3y.1.A | monomer | 0.87 | 1×ZN; | 99.28 | ||
| Isoform 3 | 7q27.1.A | monomer | 0.91 | 1×ZN; 1×8KC; 5×BO3; 1×IMD; | 99.16 | ||
| Isoform 3 | 7q3y.1.A | monomer | 0.83 | 1×NAG; | 93.65 | ||
| Isoform 4 | 7q27.1.A | monomer | 0.90 | 5×BO3; 1×IMD; | 99.10 | ||
| Isoform 4 | 7q3y.1.A | monomer | 0.82 | 2×NAG; | 93.22 | ||